Feature | Total | STUMPs | Leiomyomas | p-value | OR (95% C.I) |
---|---|---|---|---|---|
Tumor marker, n (%) | |||||
 Negative | 43 (95.6%) | 19 (90.5%) | 24 (100%) | 0.21* | 0.16(0.01–3.51)a |
 Positive | 2 (4.4%) | 2 (9.5%) | 0 (0%) |  | |
Pathologic size (cm), n (%) | |||||
  < 5 (reference category) | 16 (38.1%) | 3 (16.7%) | 13 (54.2%) | 0.03†| 1 (.-.)b |
 5–10 | 16 (38.1%) | 10 (55.6%) | 6 (25%) |  | 7.22 (1.44–36.22)b |
  ≥ 10 | 10 (23.8%) | 5 (27.8%) | 5 (20.8%) |  | 4.33 (0.74–25.29)b |
Variants of leiomyoma, n (%) | |||||
 Conventional (reference category) | 41 (91.1%) | 17 (81%) | 24 (100%) | 0.05* | 1 (.-.)a |
 Epithelioid | 3 (6.7%) | 3 (14.3%) | 0 (0%) |  | 0.1 (0–2.1)a |
 Myxoid | 1 (2.2%) | 1 (4.8%) | 0 (0%) |  | 0.24 (0.01–6.2)a |
Mitosis (cm), n (%) | |||||
  < 5 | 44 (97.8%) | 20 (95.2%) | 24 (100%) | 0.47* | 0.28 (0.01–7.22)a |
 5–10 | 1 (2.2%) | 1 (4.8%) | 0 (0%) |  | |
Necrosis, n (%) | |||||
 No (reference category) | 36 (80%) | 12 (57.1%) | 24 (100%) |  < 0.001* | 1 (.-.)a |
 Hyaline | 5 (11.1%) | 5 (23.8%) | 0 (0%) |  | 0.05 (0.0–0.91)a |
 Coagulation | 4 (8.9%) | 4 (19%) | 0 (0%) |  | 0.06 (0.0–1.14)a |
Atypia severity, n (%) | |||||
 No (reference category) | 29 (64.4%) | 5 (23.8%) | 24 (100%) |  < 0.001* | 1 (.-.)a |
 Mild to moderate | 5 (11.1%) | 5 (23.8%) | 0 (0%) |  | 0.02 (0.0–0.4)a |
 Moderate to severe | 9 (20%) | 9 (42.9%) | 0 (0%) |  | 0.01 (0.0–0.22)a |
 Severe | 2 (4.4%) | 2 (9.5%) | 0 (0%) |  | 0.04 (0.0–1.07)a |
Atypia distribution, n (%) | |||||
 No | 29 (64.4%) | 5 (23.8%) | 24 (100%) |  < 0.001* | 1 (.-.)a |
 Focal | 8 (17.8%) | 8 (38.1%) | 0 (0%) |  | 0.01 (0–0.26)a |
 Diffuse | 8 (17.8%) | 8 (38.1%) | 0 (0%) |  | 0.01 (0–0.26)a |
P16, n (%) | |||||
 Negative | 32 (71.1%) | 8 (38.1%) | 24 (100%) |  < 0.001* | 0.01 (0.0007–0.24)a |
 Positive | 13 (28.9%) | 13 (61.9%) | 0 (0%) |  | |
Bcl2, n (%) | |||||
 Negative | 19 (42.2%) | 5 (23.8%) | 14 (58.3%) | 0.03†| 0.22 (0.06–0.81)b |
 Positive | 26 (57.8%) | 16 (76.2%) | 10 (41.7%) |  | |
P53 | |||||
 Negative | 45 (100%) | 21 (100%) | 24 (100%) |  | 0.88 (0.02–46.15)a |
 Positive | 0 (0%) | 0 (0%) | 0 (0%) |  |